Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study
- 1 May 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 28 (5) , 856-864
- https://doi.org/10.1016/s0168-8278(98)80237-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double-blind studyHepatology, 1997
- Hepatic encephalopathy and brain edema in acute hepatic failure: Does glutamate play a role?Hepatology, 1997
- Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in ratsHepatology, 1997
- Modulation of ligand binding to components of the GABAA receptor complex by ammonia: implications for the pathogenesis of hyperammonemic syndromesBrain Research, 1996
- Manganese and chronic hepatic encephalopathyThe Lancet, 1995
- Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover designJournal of Hepatology, 1993
- Ammonia potentiates GABAA response in dissociated rat cortical neuronsNeuroscience Letters, 1993
- Effect of ammonium ions on synaptic transmission in the mammalian central nervous systemProgress in Neurobiology, 1992
- Synaptic transmission in ammonia intoxicationNeurochemical Pathology, 1987
- Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathyDigestive Diseases and Sciences, 1977